THE DEFINITIVE GUIDE TO PHARMACEUTICAL INGREDIENTS

“The current predicament has exposed some structural weaknesses from the EU’s medicines source chain as well as a higher dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides claimed. She suggested that supply chain challenges be dealt with within an EU pharmaceutical system envisioned being introduc